Kite Pharma is flying high with the addition of a new member to its senior leadership team. Brian Heath has joined Gilead Sciences’ cell therapy subsidiary as a senior vice president and head of ...
Financial writer recommends buying Kite Realty post-2021 merger, citing strong balance sheet, tenant diversification, and ...
EMERYVILLE — Officials cited two store clerks this week for selling alcohol to minors. The Emeryville Police Department, along with agents from the California Department of Alcoholic Beverage ...
EMERYVILLE — Officials cited two store clerks this week for selling alcohol to minors. The Emeryville Police Department, along with agents from the California Department of Alcoholic Beverage ...
Kite Pharma’s share price has dived after it emerged that a patient has died from cerebral oedema while being treated with its CAR-T therapy, KTE-C19. Investors were spooked by the news ...
Gilead’s $11.9 billion purchase of Kite Pharma in 2017 didn’t follow the script, with two big write-downs in the value of the asset since then, but a fresh approval for a CAR-T therapy could ...
Lobo, who is also an orthopaedic doctor, competed in kite surfing at the 2024 Paris Olympics. He is also a two-time Pan American Games champion. At the time of the rescue, he was busy training ...
The past two years have been punishing for the biotech and pharma space. As Wall Street chased the artificial-intelligence boom, drugmakers were left behind, with pharma stocks trading at a ...
As I step into Rajeev Juneja’s office at Mankind Pharma’s Delhi headquarters, the wall in front of me immediately commands attention. It features a collection of iconic quotes and striking ...
Each year at the J.P. Morgan Healthcare Conference, pharma CEOs are tasked with assuring and convincing investors that they’ve positioned their companies to overcome expected challenges.
CEOs of some of the largest drugmakers said this week they were encouraged after Trump said at a meeting with pharma executives late last year that these middlemen need to be eliminated.
The Impact of the US Biosecure Act on Global Pharma Manufacturing The US Biosecure Act has significant implications for the global pharmaceutical supply chain. By restricting Chinese companies ...